Evidence map›Paper›PMID 30352910›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway.

Liana Adam, F Anthony San Lucas, Richard Fowler, Yao Yu, Wenhui Wu, Yulun Liu, Huamin Wang, David Menter, Michael T Tetzlaff, Joe Ensor and 6 more

Abstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Frontiers in oncology · 2022
    Article
  10. Carbonic Anhydrases II and IX in Non-ampullary Duodenal Adenomas and Adenocarcinoma.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2021
    Article
  11. Small Bowel Epithelial Precursor Lesions: A Focus on Molecular Alterations.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Liana AdamDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
F Anthony San LucasDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Richard FowlerDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Yao YuDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Wenhui WuDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Yulun LiuDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Huamin WangDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
David MenterDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Michael T TetzlaffDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Joe EnsorHouston Methodist Cancer Center, Houston Methodist Research Institute, Houston, Texas.
Ganiraju ManyamDepartment of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Stefan T AroldKing Abdullah University of Science and Technology, Computational Bioscience Research Center, Division of Biological and Environmental Sciences and Engineering, Thuwal, Saudi Arabia.ORCID 0000-0001-5278-0668
Chad HuffDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Scott KopetzDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Paul ScheetDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Michael J OvermanDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. moverman@mdanderson.org.ORCID 0000-0001-5377-135X
The University of Texas MD Anderson Cancer Center · USHouston Methodist · USKing Abdullah University of Science and Technology · SA

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

purposeLittle is known about the genetic alterations characteristic of small bowel adenocarcinoma (SBA). Our purpose was to identify targetable alterations and develop experimental models of this disease.

resultsWES identified somatic mutations in 4 canonical pathways (WNT, ERBB2, STAT3, and chromatin remodeling), which were validated in the TES cohort. Although

conclusionsThe

Indexed as

MutationSignal TransductionAdenocarcinomaAnimalsBiomarkers, TumorCell Line, TumorDisease Models, AnimalDNA Copy Number VariationsErb-b2 Receptor Tyrosine KinasesExome SequencingFemaleHumansImmunohistochemistryIntestinal NeoplasmsIntestine, SmallMaleBiomarkers, TumorERBB2 protein, humanErb-b2 Receptor Tyrosine Kinases

Identifiers

PMID30352910
PMCPMC6335167
OpenAlexW2897178630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.